Drug Trial Radar · NCT02348203
Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers
Last checked: Nov 20, 2026Latest source record: Jun 2, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
63
Actual
Start
Jan 13, 2016
Primary completion
Feb 22, 2019
Study completion Mar 9, 2021
Sponsor
- Lead sponsor
- National Cancer Institute (NCI)NIH
- Sponsor type
- NIH
- First posted
- Jan 28, 2015
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This randomized phase II trial studies the effects of aspirin and zileuton on genes related to tobacco use in current smokers. Aspirin and zileuton may interfere with genes related to tobacco use and may be useful in preventing lung cancer in current smokers.
Conditions
- Tobacco Use Disorder
Interventions
AspirinDrug
Given PO
Laboratory Biomarker AnalysisOther
Correlative studies
Placebo AdministrationOther
Given aspirin placebo PO
Placebo AdministrationOther
Given zileuton placebo PO
ZileutonDrug
Given PO
Primary outcomes
What the sponsor says the trial is designed to measure.
- Changes in a Smoking-related Gene Expression Signature Score in the Nasal Epithelium of Current SmokersTime frame: Baseline to 12 weeks (End-of-intervention)
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Banner University Medical Center - Tucson
Tucson, Arizona
Boston University School of Medicine
Boston, Massachusetts
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.